H-1B & Green Card Sponsorship Data
Source: US Dept of Labor. Represents Base Salary only. Excludes RSUs, signing bonuses, and variable compensation. View All Salary RecordsTotal Filings
2021-PresentApproval Rate
Certified CasesMedian Salary
Across All Roles| Program | Last Filing | Dated filings (2021–Present) |
|---|---|---|
| H-1B | May 13, 2026 | 20 |
| E-3 | Nov 5, 2025 | 7 |
| PERM | Mar 11, 2024 | 2 |
| H-1B1 | Sep 26, 2023 | 3 |
| Role | Last Filing | Dated filings (2021–Present) |
|---|---|---|
| VP, Biotechnology Equity Research | May 13, 2026 | 1 |
| Investment Banking Associate II | Apr 21, 2026 | 2 |
| Managing Director, Australian Equity Sales - Americas | Apr 21, 2026 | 1 |
| DIRECTOR, AUSTRALIA EQUITY SALES | Nov 5, 2025 | 1 |
| Second Year Banking Associate | Aug 19, 2025 | 1 |
| Role | Count | Median Salary | Min | Max |
|---|---|---|---|---|
| BANKING ANALYST | 6 | $110,000 | $100,000 | $120,000 |
| INVESTMENT BANKING ANALYST | 3 | $100,000 | $100,000 | $135,000 |
| Associate, Australian Desk Salesperson | 2 | $110,000 | $110,000 | $110,000 |
| Director, Australian Equities | 2 | $175,000 | $175,000 | $175,000 |
| Director, Investment Banking | 2 | $232,500 | $215,000 | $250,000 |
| Director, Salesperson | 2 | $110,000 | $100,000 | $120,000 |
| Investment Banking Associate II | 2 | $170,000 | $160,000 | $180,000 |
| Research Associate, Biotechnology | 2 | $130,000 | $125,000 | $135,000 |
| Analyst (2nd Year) | 1 | $105,000 | $105,000 | $105,000 |
| Analyst (3rd Year) | 1 | $120,000 | $120,000 | $120,000 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2022 | 8 | $140,000 | 50.0% |
| 2023 | 9 | $110,000 | 44.4% |
| 2024 | 2 | $147,500 | 100.0% |
| 2025 | 9 | $145,000 | 88.9% |
| 2026 | 4 | $175,000 | 100.0% |
| Program | Median Days | Avg Days | P25–P75 | Cases |
|---|---|---|---|---|
| H-1B | 7 | 111 | 7–177 | 20 |